Position in ABBV
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$17,153,039
+$1,902,423 QoQ
Shares Held
68,165
-2.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#678
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 23%
Shared 0%
None 77%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Diversified Trust Co holds $139,775,642 across 13 Drug Manufacturers - General names. ABBV ranks #4 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
29,940 | $35,910,936 | |
| 2 | JNJ |
Johnson & Johnson
|
112,529 | $28,578,989 | |
| 3 | MRK |
Merck & Co., Inc.
|
194,020 | $24,931,570 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
68,165 | $17,153,039 | |
| 5 | AMGN |
Amgen Inc
|
33,837 | $12,253,054 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
55,634 | $7,028,799 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
90,768 | $5,230,051 | |
| 8 | PFE |
Pfizer Inc
|
150,996 | $3,635,983 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,153,039 | 68,165 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $15,250,616 | 70,121 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $14,095,775 | 61,691 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $13,215,376 | 57,076 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $8,572,858 | 46,185 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $9,894,371 | 47,224 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $7,440,298 | 41,870 | Shares | Sole | 2025-01-07 | |
| 2024-09-30 | $7,892,485 | 39,966 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $6,284,835 | 36,642 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $7,833,395 | 43,017 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $7,305,129 | 47,139 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $7,030,712 | 47,167 | Shares | Sole | 2023-11-17 | |
| 2023-06-30 | $6,103,672 | 45,303 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $7,210,854 | 45,246 | Shares | Sole | 2023-04-07 | |
| 2022-12-31 | $6,901,069 | 42,702 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $4,580,989 | 34,133 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $6,567,807 | 42,882 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $5,809,698 | 35,838 | Shares | Sole | 2022-04-07 | |
| 2021-12-31 | $3,316,081 | 24,491 | Shares | Sole | 2022-01-13 | |
| 2021-09-30 | $2,177,463 | 20,186 | Shares | Sole | 2022-01-13 | |
| 2021-06-30 | $2,262,599 | 20,087 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $2,168,187 | 20,035 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $2,136,463 | 19,939 | Shares | Sole | 2021-01-08 | |
| 2020-09-30 | $1,808,120 | 20,643 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $1,998,748 | 20,358 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $1,095,231 | 14,375 | Shares | Sole | 2020-04-10 | |
| No filing history on record for this holder in this stock. | ||||||